Patents
Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
04/2002
04/30/2002US6380180 Potassium channel blocking agents
04/25/2002WO2002032875A1 Agent which inactivates pathogens, comprising an element that bonds with nucleic acids and the use thereof
04/25/2002US20020049246 Benzimidazole compounds for treatment of asthma, vasospasm, memory loss, migraine and others diseases associated with potassium channels
04/25/2002US20020048271 Methods and composition for restoring conformational stability of a protein of the p53 family
04/18/2002WO2001087830A3 Substituted thioacetamides
04/18/2002US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/18/2002US20020045228 Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
04/11/2002WO2002028837A1 Metabotropic glutamate receptor antagonists
04/11/2002US20020041888 Suspension containing microspheres; apoptosis inducing compound
04/11/2002DE10047480A1 Use of acridine-aldehydes and/or -ketones, some of which are novel compounds, in dyeing hair in a wide variety of intense shades, even in the absence of oxidizers
04/11/2002CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists
04/02/2002US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
03/2002
03/28/2002US20020037254 Conjugate for differentiating between healthy and unhealthy tissue
03/26/2002CA2005925C Compositions and new pharmaceutical products for the regeneration of leucocytes and their use in the treatment of the immunodeficiency syndrome
03/21/2002US20020034828 Bound to analyte or its ligand by biotin-avidin or biotin-streptavidin bridge; reacts with analyte or its ligand bound to solid phase; signal solution added; emitted light proportional to concentration of analyte or its ligand
03/20/2002EP0915851B1 Dibenzodihydropyridinecarboxylic esters and their use in chemiluminescent assay methods
03/14/2002WO2001060801A3 9-alkylamino-1-nitroacridine derivatives
03/13/2002EP1185493A1 Quinones for treatment of diseases
03/12/2002US6355803 Compound comprising extended, coplanar, conjugated system, formed by attachment of functional group comprising aromatic ring and electron-donating group on acridinium nucleus, which maintains coplanarity during light emission
03/07/2002DE10035928A1 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel New heteroaryl derivatives and their use as medicaments
03/07/2002DE10035927A1 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel New heteroaryl derivatives and their use as medicaments
03/07/2002DE10035908A1 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel New heteroaryl derivatives and their use as medicaments
02/2002
02/20/2002EP0915865B1 Covalently immobilised fluoroionophores for optical ion sensors
02/13/2002CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use
02/06/2002EP1177197A2 Polyamines and their use in therapy
01/2002
01/31/2002WO2002008194A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals
01/31/2002WO2002008193A2 Therapeutic acridone and acridine compounds
01/31/2002WO2002008192A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals
01/31/2002WO2002008190A2 Novel heteroaryl derivatives and use thereof as anti-tumour agents
01/30/2002EP0944600B1 Process for converting hydroxy heteroaromatics to arylamines
01/29/2002CA1341335C 9-amino-1, 4 ethano-1, 2, 3, 4-tetrahydroacridine and related compounds, intermediates and a process for the preparation thereof an their use as medicaments
01/24/2002US20020009650 High electroconductivity
01/23/2002EP1173414A1 N-protected amines and their use as prodrugs
01/23/2002EP1173223A2 Conjugates as therapies for cancers and prostate diseases
01/21/2002CA2353369A1 Novel heteroaryl derivatives and their use as medicaments
01/21/2002CA2353360A1 Novel heteroaryl derivatives and their use as medicaments
01/21/2002CA2353353A1 Novel heteroaryl derivatives and their use as medicaments
01/09/2002EP1169298A2 Pharmaceutical compounds
01/09/2002EP1169294A2 Pharmaceutical compounds
01/03/2002WO2002000726A1 Electrochemiluminescence from acridan compounds
01/02/2002EP0892801B1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents
01/02/2002CN1329493A Methods and compositions for restoring conformational stability of a protein of the p53 family
12/2001
12/27/2001WO2001064645A3 Derivatives of quinoline as alpha-2 antagonists
12/27/2001WO2000064864A9 N-protected amines and their use as prodrugs
12/25/2001US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation
12/25/2001CA2053640C Quinoline derivatives
12/19/2001CN1327468A Organic electroluminescent element
12/18/2001US6331640 Diaminopropionic acid derivatives
12/18/2001US6331549 Treatment of urinary stress incontinence, venous insufficiency, venous ulcers, migraine or gastrointestinal disorders
12/12/2001EP0968175B1 Spiro compounds and the use thereof
12/06/2001WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/05/2001EP1159261A2 Antizyme modulators and their use
12/05/2001EP0750748B1 Novel aryl n-alkylacridancarboxylate derivatives useful for chemiluminescent detection
11/2001
11/29/2001US20010046991 P-aminoanilino- derivatives
11/22/2001WO2001087830A2 Substituted thioacetamides
11/22/2001CA2409116A1 Substituted thioacetamides
11/21/2001CN1323291A Diaminopropionic acid derivatives
11/20/2001US6319428 Perfluorinated amide salts and their uses as ionic conducting materials
11/08/2001WO2001083484A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/08/2001US20010039345 Novel compounds for generating chemiluminescence with a peroxidase
10/2001
10/25/2001WO2000061541A8 Pharmaceutical compounds
10/25/2001US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/18/2001WO2001076567A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
10/18/2001US20010031869 Formation of bond between nitrogen atom of acridan ring and carbon atom of another aromatic or heteroaromatic ring compound; assays for peroxidase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs
10/18/2001US20010031763 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents
10/18/2001CA2406484A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
10/10/2001EP1140888A1 Optical molecular sensors for cytochrome p450 activity
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/04/2001EP1138745A1 Organic electroluminescent element
10/04/2001EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
10/02/2001US6296787 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
09/2001
09/27/2001WO2001070699A1 Azure a analogues useful as probes in the diagnostic imaging for diseases due to accumulation of amyloid and compositions for diagnostic imaging containing the analogues
09/27/2001WO2001060822A8 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
09/27/2001WO2000061541A3 Pharmaceutical compounds
09/27/2001WO2000061537A3 Pharmaceutical compounds
09/27/2001US20010024749 Surface modified carbonaceous materials
09/25/2001US6294390 Compound consisting of ionophore, fluorophore, and a functional group bound together through a trivalent organic radical; sensors having long usable life and a high degree of sensitivity
09/18/2001US6291702 As agents for trapping and identifying free radical species and find use as efficient antioxidants in physicochemical and biological systems.
09/18/2001US6291172 Diagnostic assay for diabetes mellitus based on mutational burden
09/18/2001US6290926 Catalysis of carbon monoxide conversion via the water-gas shift reaction
09/18/2001CA2022297C Derivatives of 1,2,3,4-tetrahydro-9-acridinamine
09/13/2001US20010021526 Immortal rho degrees cell line; undifferentiated cells for drug screening; alzheimers, huntington's disease, myoclonic epilepsy lactic acidosis and stroke (MELAS); myoclonic epilepsy ragged red fiber (MERRF)
09/12/2001EP1131293A1 1-aminoethylquinoline derivatives for treating urinary incontinence
09/07/2001WO2001064645A2 Derivatives of quinoline as alpha-2 antagonists
09/07/2001CA2400657A1 Derivatives of quinoline as alpha-2 antagonists
08/2001
08/30/2001US20010018179 Porous adsorbent particles immobilized on matrix
08/28/2001US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
08/23/2001WO2001060822A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
08/23/2001WO2001060801A2 9-alkylamino-1-nitroacridine derivatives
08/23/2001CA2400537A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
08/22/2001EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
08/14/2001US6274768 Acridin derivatives
08/08/2001EP1121342A1 Diaminopropionic acid derivatives
08/07/2001US6270695 Heterocyclic compounds with exocyclic double bond having phosphate group attached to distal carbon; detection sensitivity
08/02/2001WO2000066175A3 Conjugates as therapies for cancer and prostate diseases
08/01/2001EP1119554A1 Xanthan-ester and acridan substrates for horseradish peroxidase
07/2001
07/26/2001US20010009914 Acridone-derived compounds useful as antineoplastic and antiretroviral agents
07/26/2001US20010009756 Flow devices for the reduction of compounds from biological compositions and methods of use
07/24/2001US6265431 Cycloalkano-indole and -azaindole derivatives
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22